Boards & Committees - Int'l Thoracic Tx Registry

(Parentheses after name indicates year rotating off Committee)

Tuesday, April 10, 2018, 5:00-7:00 PM
Room: Gallieni 4

ISHLT 38th Annual Meeting and Scientific Sessions
Acropolis Congrès Centre
Nice, France


  • The International Thoracic Organ Transplant Registry Committee shall consist of the Medical Director, a Senior and an  Associate Medical Director for Adult Heart Transplantation, a Senior and an Associate Medical Director for Adult Lung/Heart-Lung Transplantation, a Senior and an Associate Medical Director for Pediatric Heart Transplantation, a Senior and an Associate Medical Director for Pediatric Lung/Heart-Lung Transplantation, an Associate Medical Director for Outcomes, an Associate Director for rgan exchange organization (OEO) Relations, an Associate Director for Biostatistics, and staff from the data coordinating center contracted to manage the registry.
  • The Medical Director shall be appointed by the Board for a five-year term, renewable once.
  • Committee members shall be appointed by the Medical Director and approved by the Board for 5-year, non-renewable, staggered terms. In the first 2 years they will overlap and work along with the current Associate Director. In their last 2 years they will provide mentorship to the incoming Associate Medical Director.
  • Before the appointment of a new committee member is due, relevant Council Chairs will be approached and asked to solicit nominations from among the Council’s membership for appointment to the Committee. Such nominations shall be submitted to the Chair for consideration.
Medical Director Responsibilities:

  • The Medical Director shall serve as an ex-officio, non-voting member of the Board.
  • The Medical Director may receive an annual stipend established by the Board of Directors.
  • The Medical Director must report to the Board, to include the following:
    • Summary of the prior year data collection
    • Status of deliverables from the prior year
    • List of publications arising from the registry during the prior year
    • Assessment of need to continuing to operate registry
    • Plans for the coming year including proposed deliverables / publications
  • The duties of the Medical Director shall include maintaining the scientific integrity of the Registry, working within the budget as set by the Board of Directors, and achieving the goals and objectives set for the Registry.
  • The Medical Director shall develop and form relationships with governmental and professional organizations worldwide overseeing thoracic organ transplantation and transplant data collection.

  • Oversee the operation of the registry and monitor its ongoing progress, participation rates, and cost-benefit ratio.
  • Conduct regular evaluations regarding the need to continue to operate the registry.
  • Identify and revise, as needed, data collection fields and definitions that facilitate the collection of appropriate information.
  • Interface with individual centers and organ exchange organizations to encourage submission of data to the Registry.
  • Interface with individual centers and organ exchange organizations to enhance compliance with data collection.
  • Review abstracts and manuscripts generated with the use of Registry data prior to submission for peer-review/publication.
  • Review results of data collection and generate regular Annual Data Reports.
  • Authorize, review, and approve the submission of requests for access to the data for scientific studies.
  • Initiate and facilitate data analysis projects.
  • Oversee compliance with data use agreements.
  • Achieve the goals and objectives established annually by the Board for the Registry.


Marshall Hertz, MD

Jeffrey D. Hosenpud, MD

Michael P. Kaye, MD

Josef Stehlik, MD, MPH (July 2022)
University of Utah
Salt Lake City, Utah, USA

Josef Stehlik, MD, MPH is an Associate Professor of Medicine at the University of Utah School of Medicine. Dr. Stehlik received his medical degree from Charles University in Prague and Masters in Public Health degree from Harvard School of Public Health. He completed his training in Internal Medicine and in Cardiovascular Diseases at Allegheny General Hospital, MCP*Hahnemann University and advanced training in Heart Failure and Transplantation at the Cleveland Clinic. Dr. Stehlik has been on faculty at the University of Utah since 2004 and serves as Medical Director of the Heart Transplant Program at the University of Utah Hospital and the Salt Lake City Veterans Affairs Medical Center. He has been active in clinical work, education and research in the areas of advanced heart failure, heart transplantation and mechanical circulatory support.

Jeffrey J. Teuteberg, MD
Stanford University School of Medicine
Stanford, CA, USA


Kiran K. Khush, MD (Sept 2021)
Stanford University
Stanford, CA, USA

Bio coming soon...

Daniel C. Chambers, MBBS MRCP FRACP MD (Sept 2021)
The Prince Charles Hospital

Bio coming soon...

Joseph W. Rossano, MD (Sept 2019)
The Children's Hospital
Philadelphia, PA, USA

Dr. Rossano attended medical school at the University of Arizona College of Medicine and Seattle Children’s Hospital for his pediatric residency. He moved to Houston for pediatric cardiology fellowship training and there underwent additional fellowship training in cardiac intensive care and heart failure / transplantation. While on the faculty of Baylor College of Medicine and Texas Children’s hospital he obtained Masters of Science degree in clinical research. He moved on to the Children’s Hospital of Philadelphia and the University of Pennsylvania where he is the Medical Director of the Heart Failure and Transplantation Program and the Interim Medical Director of the Cardiac Intensive Care Unit. He is actively engaged in clinical outcomes research.

Samuel B. Goldfarb, MD (Sept 2018)
The Children's Hospital of Philadelphia
Philadelphia, PA, USA

Bio coming soon...


Bronwyn J. Levvey, RN, Grad Dip Clin Ep (Sept 2018)
Alfred Hospital
Melbourne, AUSTRALIA

A/Prof Bronwyn Levvey is the clinical lung transplant nursing team leader of the Lung Transplant Service at The Alfred Hospital, Melbourne Australia. Appointed as Adjunct Clinical Associate Professor in the Department of Medicine, Faculty of Nursing & Health Sciences at Monash University (Melbourne) in 2008 in recognition of her strong commitment to transplantation nursing education and clinical research, she has authored or co-authored more than 60 peer review scientific publications. Since 2005, a major focus of A/Prof Levvey’s clinical research has been the successful evolution and development of Category III DCD Lung donation and transplantation in Australia. An ISHLT member since 2000, she is the current National President of the Transplant Nurses Association (TNA) of Australia, a member of TTS and the Transplantation Society of Australia & New Zealand (TSANZ), and is a member of several Australian government organ donation and transplantation advisory boards.

Bruno M. Meiser, MD (Sept 2018)
University Munich/Grosshadern
Transplant Center Munich

Bio coming soon...

Wida S. Cherikh, PhD
United Network for Organ Sharing
Richmond, Virginia, USA

Bio coming soon...

Anna Kucheryavaya, MS
United Network for Organ Sharing
Richmond, Virginia, USA

Bio coming soon...

Text SizeIncrease Font SizeDecrease Font Size